COMPARISON OF ATRIAL FIBRILLATION ABLATION BLEEDING AND THROMBOTIC COMPLICATIONS WITH DABIGATRAN, RIVAROXABAN AND WARFARIN

被引：7
|
作者：
Bernard, Michael [1 ]
Brabham, William [1 ]
Netzler, Peter [1 ]
Rowley, Christopher [1 ]
Gold, Michael [1 ]
Leman, Robert [1 ]
Sturdivant, John [1 ]
Wharton, J. Marcus [1 ]
Cuoco, Frank [1 ]
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 61卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(13)60276-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E276 / E276
页数：1
相关论文
共 50 条
  • [21] Safety of dabigatran or rivaroxaban for thoracoscopic ablation in patients with atrial fibrillation
    Im, Sung Il
    Jeong, Dong Seop
    Park, Seung-Jung
    Park, Kyoung-Min
    Huh, June
    Kim, June Soo
    On, Young Keun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 186 : 213 - 215
  • [22] An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation
    Mantha, Simon
    Ansell, Jack
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (03) : 476 - 484
  • [23] Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study
    Ellis, Martin H.
    Neuman, Tsipora
    Bitterman, Haim
    Dotan, Sari Greenberg
    Hammerman, Ariel
    Battat, Erez
    Eikelboom, John W.
    Ginsberg, Jeffrey S.
    Hirsh, Jack
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 55 - 59
  • [24] Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation Reply
    Calkins, Hugh
    Nordaby, Matias
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05): : 495 - 496
  • [25] Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
    Kim, Jin-Seok
    She, Fei
    Jongnarangsin, Krit
    Chugh, Aman
    Latchamsetty, Rakesh
    Ghanbari, Hamid
    Crawford, Thomas
    Suwanagool, Arisara
    Sinno, Mohammed
    Carrigan, Thomas
    Kennedy, Robert
    Saint-Phard, Wouter
    Yokokawa, Miki
    Good, Eric
    Bogun, Frank
    Pelosi, Frank, Jr.
    Morady, Fred
    Oral, Hakan
    HEART RHYTHM, 2013, 10 (04) : 483 - 489
  • [26] The Incidence of Asymptomatic Cerebral Microthromboembolism after Atrial Fibrillation Ablation: Comparison of Warfarin and Dabigatran
    Ichiki, Hitoshi
    Oketani, Naoya
    Ishida, Sanemasa
    Iriki, Yasuhisa
    Okui, Hideki
    Maenosono, Ryuichi
    Namino, Fuminori
    Ninomiya, Yuichi
    Miyata, Masaaki
    Hamasaki, Shuichi
    Tei, Chuwa
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (11): : 1328 - 1335
  • [27] Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
    Sjalander, Sara
    Sjogren, Vilhelm
    Renlund, Henrik
    Norrving, Bo
    Sjalander, Anders
    THROMBOSIS RESEARCH, 2018, 167 : 113 - 118
  • [28] Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
    Torbjørn Wisløff
    Gunhild Hagen
    Marianne Klemp
    PharmacoEconomics, 2014, 32 : 601 - 612
  • [29] Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
    Wisloff, Torbjorn
    Hagen, Gunhild
    Klemp, Marianne
    PHARMACOECONOMICS, 2014, 32 (06) : 601 - 612
  • [30] Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
    Chan, Yi-Hsin
    See, Lai-Chu
    Tu, Hui-Tzu
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    Wang, Chun-Li
    Kuo, Chang-Fu
    Kuo, Chi-Tai
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
12345